Logo image of MRCY

MERCURY SYSTEMS INC (MRCY) Stock Fundamental Analysis

NASDAQ:MRCY - Nasdaq - US5893781089 - Common Stock - Currency: USD

52.98  +1.41 (+2.73%)

After market: 53.7 +0.72 (+1.36%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to MRCY. MRCY was compared to 65 industry peers in the Aerospace & Defense industry. While MRCY seems to be doing ok healthwise, there are quite some concerns on its profitability. MRCY has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

MRCY had positive earnings in the past year.
In the past year MRCY had a positive cash flow from operations.
In multiple years MRCY reported negative net income over the last 5 years.
In multiple years MRCY reported negative operating cash flow during the last 5 years.
MRCY Yearly Net Income VS EBIT VS OCF VS FCFMRCY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M

1.2 Ratios

With a Return On Assets value of -2.69%, MRCY is not doing good in the industry: 67.69% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -4.48%, MRCY is doing worse than 64.62% of the companies in the same industry.
Industry RankSector Rank
ROA -2.69%
ROE -4.48%
ROIC N/A
ROA(3y)-2.16%
ROA(5y)0.4%
ROE(3y)-3.47%
ROE(5y)-0.01%
ROIC(3y)N/A
ROIC(5y)N/A
MRCY Yearly ROA, ROE, ROICMRCY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5

1.3 Margins

MRCY has a Gross Margin (27.37%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of MRCY has declined.
MRCY does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 27.37%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-17.45%
GM growth 5Y-11.71%
MRCY Yearly Profit, Operating, Gross MarginsMRCY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

5

2. Health

2.1 Basic Checks

MRCY does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for MRCY has been increased compared to 1 year ago.
MRCY has more shares outstanding than it did 5 years ago.
MRCY has a worse debt/assets ratio than last year.
MRCY Yearly Shares OutstandingMRCY Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
MRCY Yearly Total Debt VS Total AssetsMRCY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

MRCY has an Altman-Z score of 2.69. This is not the best score and indicates that MRCY is in the grey zone with still only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.69, MRCY perfoms like the industry average, outperforming 44.62% of the companies in the same industry.
MRCY has a debt to FCF ratio of 4.04. This is a neutral value as MRCY would need 4.04 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 4.04, MRCY is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
A Debt/Equity ratio of 0.41 indicates that MRCY is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.41, MRCY is doing good in the industry, outperforming 61.54% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF 4.04
Altman-Z 2.69
ROIC/WACCN/A
WACC10.11%
MRCY Yearly LT Debt VS Equity VS FCFMRCY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 3.44 indicates that MRCY has no problem at all paying its short term obligations.
MRCY has a Current ratio of 3.44. This is in the better half of the industry: MRCY outperforms 73.85% of its industry peers.
MRCY has a Quick Ratio of 2.25. This indicates that MRCY is financially healthy and has no problem in meeting its short term obligations.
MRCY has a better Quick ratio (2.25) than 73.85% of its industry peers.
Industry RankSector Rank
Current Ratio 3.44
Quick Ratio 2.25
MRCY Yearly Current Assets VS Current LiabilitesMRCY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

5

3. Growth

3.1 Past

MRCY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 158.02%, which is quite impressive.
MRCY shows a small growth in Revenue. In the last year, the Revenue has grown by 5.66%.
MRCY shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.99% yearly.
EPS 1Y (TTM)158.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%123.08%
Revenue 1Y (TTM)5.66%
Revenue growth 3Y-3.31%
Revenue growth 5Y4.99%
Sales Q2Q%1.49%

3.2 Future

Based on estimates for the next years, MRCY will show a very strong growth in Earnings Per Share. The EPS will grow by 62.79% on average per year.
The Revenue is expected to grow by 7.03% on average over the next years.
EPS Next Y169.1%
EPS Next 2Y86.56%
EPS Next 3Y62.79%
EPS Next 5YN/A
Revenue Next Year7.85%
Revenue Next 2Y7.01%
Revenue Next 3Y7.03%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
MRCY Yearly Revenue VS EstimatesMRCY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
MRCY Yearly EPS VS EstimatesMRCY Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 2

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 112.72 indicates a quite expensive valuation of MRCY.
MRCY's Price/Earnings ratio is in line with the industry average.
The average S&P500 Price/Earnings ratio is at 26.31. MRCY is valued rather expensively when compared to this.
The Price/Forward Earnings ratio is 57.71, which means the current valuation is very expensive for MRCY.
60.00% of the companies in the same industry are cheaper than MRCY, based on the Price/Forward Earnings ratio.
MRCY's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.13.
Industry RankSector Rank
PE 112.72
Fwd PE 57.71
MRCY Price Earnings VS Forward Price EarningsMRCY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MRCY is valued a bit more expensive than the industry average as 63.08% of the companies are valued more cheaply.
Based on the Price/Free Cash Flow ratio, MRCY is valued cheaply inside the industry as 93.85% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 21.61
EV/EBITDA 71.96
MRCY Per share dataMRCY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

MRCY's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as MRCY's earnings are expected to grow with 62.79% in the coming years.
PEG (NY)0.67
PEG (5Y)N/A
EPS Next 2Y86.56%
EPS Next 3Y62.79%

0

5. Dividend

5.1 Amount

No dividends for MRCY!.
Industry RankSector Rank
Dividend Yield N/A

MERCURY SYSTEMS INC

NASDAQ:MRCY (6/13/2025, 8:24:02 PM)

After market: 53.7 +0.72 (+1.36%)

52.98

+1.41 (+2.73%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)05-06 2025-05-06/amc
Earnings (Next)08-11 2025-08-11/amc
Inst Owners109.29%
Inst Owner Change-0.5%
Ins Owners1.86%
Ins Owner Change-1.17%
Market Cap3.17B
Analysts74.67
Price Target51.34 (-3.1%)
Short Float %7.24%
Short Ratio7.36
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)117.5%
Min EPS beat(2)-26.47%
Max EPS beat(2)261.48%
EPS beat(4)3
Avg EPS beat(4)1121.43%
Min EPS beat(4)-26.47%
Max EPS beat(4)4101.68%
EPS beat(8)3
Avg EPS beat(8)306.78%
EPS beat(12)5
Avg EPS beat(12)202.43%
EPS beat(16)7
Avg EPS beat(16)151.38%
Revenue beat(2)2
Avg Revenue beat(2)10.68%
Min Revenue beat(2)1.44%
Max Revenue beat(2)19.92%
Revenue beat(4)4
Avg Revenue beat(4)9.31%
Min Revenue beat(4)1.44%
Max Revenue beat(4)19.92%
Revenue beat(8)4
Avg Revenue beat(8)-1.03%
Revenue beat(12)6
Avg Revenue beat(12)-1.23%
Revenue beat(16)8
Avg Revenue beat(16)-0.93%
PT rev (1m)3.42%
PT rev (3m)17.05%
EPS NQ rev (1m)6.36%
EPS NQ rev (3m)6.36%
EPS NY rev (1m)0.6%
EPS NY rev (3m)0.6%
Revenue NQ rev (1m)-1.71%
Revenue NQ rev (3m)-1.47%
Revenue NY rev (1m)-0.49%
Revenue NY rev (3m)-0.08%
Valuation
Industry RankSector Rank
PE 112.72
Fwd PE 57.71
P/S 3.57
P/FCF 21.61
P/OCF 18.35
P/B 2.18
P/tB 10.66
EV/EBITDA 71.96
EPS(TTM)0.47
EY0.89%
EPS(NY)0.92
Fwd EY1.73%
FCF(TTM)2.45
FCFY4.63%
OCF(TTM)2.89
OCFY5.45%
SpS14.85
BVpS24.29
TBVpS4.97
PEG (NY)0.67
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.69%
ROE -4.48%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 27.37%
FCFM 16.51%
ROA(3y)-2.16%
ROA(5y)0.4%
ROE(3y)-3.47%
ROE(5y)-0.01%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-17.45%
GM growth 5Y-11.71%
F-Score6
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF 4.04
Debt/EBITDA 12.51
Cap/Depr 31.22%
Cap/Sales 2.94%
Interest Coverage N/A
Cash Conversion 364.86%
Profit Quality N/A
Current Ratio 3.44
Quick Ratio 2.25
Altman-Z 2.69
F-Score6
WACC10.11%
ROIC/WACCN/A
Cap/Depr(3y)36.16%
Cap/Depr(5y)52.86%
Cap/Sales(3y)3.63%
Cap/Sales(5y)4.25%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)158.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%123.08%
EPS Next Y169.1%
EPS Next 2Y86.56%
EPS Next 3Y62.79%
EPS Next 5YN/A
Revenue 1Y (TTM)5.66%
Revenue growth 3Y-3.31%
Revenue growth 5Y4.99%
Sales Q2Q%1.49%
Revenue Next Year7.85%
Revenue Next 2Y7.01%
Revenue Next 3Y7.03%
Revenue Next 5YN/A
EBIT growth 1Y70.82%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year163.84%
EBIT Next 3Y47.39%
EBIT Next 5YN/A
FCF growth 1Y259.92%
FCF growth 3Y-20.33%
FCF growth 5Y-18.1%
OCF growth 1Y423.1%
OCF growth 3Y-14.67%
OCF growth 5Y-9.14%